197 related articles for article (PubMed ID: 31611349)
1. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in
Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349
[TBL] [Abstract][Full Text] [Related]
2.
Zhu Y; Kilburn S; Kapoor M; Chaturvedi S; Shaw KJ; Chaturvedi V
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839219
[TBL] [Abstract][Full Text] [Related]
3.
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp.
Trzoss M; Covel JA; Kapoor M; Moloney MK; Soltow QA; Webb PJ; Shaw KJ
Bioorg Med Chem Lett; 2019 Dec; 29(23):126713. PubMed ID: 31668974
[TBL] [Abstract][Full Text] [Related]
5. Manogepix (APX001A) Displays Potent
Arendrup MC; Jørgensen KM
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366708
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Efflux Pump Expression in
Liston SD; Whitesell L; Kapoor M; Shaw KJ; Cowen LE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32179530
[TBL] [Abstract][Full Text] [Related]
7.
Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
[No Abstract] [Full Text] [Related]
8. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.
Alkhazraji S; Gebremariam T; Alqarihi A; Gu Y; Mamouei Z; Singh S; Wiederhold NP; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818813
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304
[TBL] [Abstract][Full Text] [Related]
10.
Shaw KJ; Schell WA; Covel J; Duboc G; Giamberardino C; Kapoor M; Moloney M; Soltow QA; Tenor JL; Toffaletti DL; Trzoss M; Webb P; Perfect JR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891599
[TBL] [Abstract][Full Text] [Related]
11. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
[TBL] [Abstract][Full Text] [Related]
12.
Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14.
Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
17. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus.
Gebremariam T; Alkhazraji S; Alqarihi A; Wiederhold NP; Shaw KJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205345
[TBL] [Abstract][Full Text] [Related]
18. E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.
Watanabe NA; Miyazaki M; Horii T; Sagane K; Tsukahara K; Hata K
Antimicrob Agents Chemother; 2012 Feb; 56(2):960-71. PubMed ID: 22143530
[TBL] [Abstract][Full Text] [Related]
19. Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections.
Shaw KJ; Ibrahim AS
J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33105672
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
